EPRXEupraxia Pharmaceuticals Inc.

Healthcare
$7.58+26% 1Y

Price

+26%1Y

End-of-day closes, not the intraday tick.

The five questions

2 of 5 available

Only two of the five can be answered for EPRX today. The rest need figures this filer has not published. The tabs above still show whatever data does exist.

  • Is the business good?not enough filed
  • Is it safe?Watch
  • Is the price fair?not enough filed
  • Is it growing?not enough filed
  • What is the market doing?Good
P/En/a
Market value$495.2M
1 year+26%
5 yearsn/a

Charts

As reported to the SEC, without any scoring.

For the full year FY2025, revenue was $0 and net income −$39M.

Biotechnology

The closest names by size in the same industry

Compare peers
CTNM+3.7%
Contineum Therapeutics, Inc.
PROK+5.0%
PROKIDNEY CORP.
ARVN+0.80%
ARVINAS, INC.
ALT-2.4%
Altimmune, Inc.
ALLO-1.8%
Allogene Therapeutics, Inc.
PBYI+1.6%
PUMA BIOTECHNOLOGY, INC.